Adjuvant endocrine therapy in breast cancer

Journal Title: Współczesna Onkologia - Year 2007, Vol 11, Issue 2

Abstract

Endocrine therapy is the most important component of adjuvant therapy for patients with hormone receptor-positive breast cancer, regardless of age and menopausal status. Tamoxifen improves survival in premenopausal and postmenopausal women. In premenopausal patients it is used alone, in combination with ovarian suppression, or sequentially, after chemotherapy. Ovarian ablation/suppression in the absence of chemotherapy significantly improves survival in patients younger than 50. Combined with tamoxifen it offers an outcome similar to that of CMF chemotherapy. There is no clear benefit from adding ovarian ablation/suppression after chemotherapy. Aromatase inhibitors are now considered an integral part of endocrine therapy in postmenopausal women. They can be given as initial adjuvant treatment, sequentially with tamoxifen or as extended therapy after tamoxifen. However, neither the optimal duration nor sequencing nor long-term safety of aromatase inhibitors is known. They should not be given in premenopausal women otherwise than in clinical trials.

Authors and Affiliations

Anna Niwińska, Maria Litwiniuk

Keywords

Related Articles

Medulloblastoma in a 38-year-old patient; a case report and literature review

Medulloblastoma (MB), a malignant neuroectodermal tumour, is rare in adults, accounting for 1% of all primary tumours of the central nervous system. Maximum surgical resection followed by craniospinal irradiation with a...

Medulloblastoma u 38-letniego mężczyzny. Opis przypadku i przegląd literatury

Medulloblastoma, złośliwy guz neuroektodermalny, jest rzadko spotykany u dorosłych i stanowi ok. 1 proc. wszystkich guzów centralnego układu nerwowego. Standardem postępowania jest maksymalne usunięcie guza, z pooperacyj...

Cancer pain in children and adolescents

As far as population of growth age is concerned, every year, in Poland there are 1100 to 1300 new cases of going down with cancer. The most common cases are leukemia, tumour, lymphoma (59.3% of all children’s cancer ca...

Radiochemotherapy of glioblastoma complicated with systemic aspergillosis - case report

Recently, surgery followed by radiotherapy with temozolomide has become a standard treatment for glioblastoma patients. During chemoradiotherpy in one of our glioblastoma patients sudden respiratory failure resulted in d...

Wczesne wyniki leczenia raka gruczołu piersiowego metodą oszczędzającą

Wstęp: Rocznie notuje się 10 tys. nowych zachorowań na raka piersi. Operacje oszczędzające wykonywane są u ok. 5 proc. chorych w Polsce i 50–70 proc. chorych w Europie Zachodniej. Jest to poważny problem społeczny, gd...

Download PDF file
  • EP ID EP133931
  • DOI -
  • Views 64
  • Downloads 0

How To Cite

Anna Niwińska, Maria Litwiniuk (2007). Adjuvant endocrine therapy in breast cancer. Współczesna Onkologia, 11(2), 82-88. https://europub.co.uk./articles/-A-133931